Wie sind die Öffnungszeiten?

Montag 09:00 - 17:00 Dienstag 09:00 - 17:00 Mittwoch 09:00 - 17:00 Donnerstag 09:00 - 17:00 Freitag 09:00 - 17:00

Nanolive

Name: Nanolive
Address: Route de Lully 5B, Lully, 1131, CH
Telephone: +41213530600

: Capture dynamic, unbiased live cell data to accelerate discovery, development and therapeutics.

Nanolive delivers breakthrough 3D imaging solutions that accelerate research in growth industries such as drug discovery and cell therapy. Nanolive’s innovative solutions combine screening, imaging and analysis to radically advance how scientists study living cells and provide novel biological insights such as the mechanisms of cancer and neurodegenerative diseases.

05/06/2026

𝗖𝗮𝗹𝗹𝗶𝗻𝗴 𝗥&𝗗 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 𝗮𝗻𝗱 𝗯𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗶𝗻 𝗱𝗿𝘂𝗴 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆!

𝗜𝗳 𝘆𝗼𝘂 𝗮𝗿𝗲 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝘁𝗼:

– Accelerate drug screening and candidate selection with high-content data

– Simplify experimental workflows and data interpretation

– Reduce fragmented assays and complex data integration

– Support more informed decision-making with label-free data

𝘀𝗶𝗴𝗻 𝘂𝗽 𝘁𝗼 𝗼𝘂𝗿 𝗝𝘂𝗻𝗲 𝟭𝟳𝘁𝗵 𝘄𝗲𝗯𝗶𝗻𝗮𝗿!

Nanolive user Elizabeth Nelson will present findings from their recent publication ‘Subcellular nanoparticle trafficking investigated with label-free, live cell imaging’, and share a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles, mRNA cargo delivery and transcription, and cytotoxic responses in real time.

Register here: https://bit.ly/4xdV1zK

03/06/2026

𝗠𝗶𝘁𝗼𝘁𝗶𝗰 𝗰𝗮𝘁𝗮𝘀𝘁𝗿𝗼𝗽𝗵𝗲!
These side-by-side videos show how label-free imaging captures the intricacies of cell life and death. On the left, a cell successfully passes through the steps of mitosis; we see DNA condensation, chromosomes lining up on the equator, and separation to produce two daughter cells. On the right however, mitosis fails, causing the cell to self-destruct in a regulated form of cell death. This kind of catastrophic failure is commonly caused by DNA damage.

These videos were captured by Elizabeth Nelson during their investigation into nanoparticles and drug delivery, using the Nanolive platform. You can hear more about their work in our upcoming webinar on June 17th.

Register here: https://bit.ly/4u8moZe

01/06/2026

𝗺𝗥𝗡𝗔 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗶𝗻 𝗻𝗮𝗻𝗼𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲𝘀
Nanolive allows the label-free visualization of cells and their organelles, giving a full picture of subcellular localization, expression and cytotoxic effects of nanoparticle therapies while minimizing photoxicity. Here, 2 fluorescence channels were used: first the nanoparticles (purple) are taken up and accumulate in the cytosol, and later the mRNA cargo starts to be transcribed (green).

Join our speaker Elizabeth Nelson on June 17th as they share work from the Koch Institute at MIT, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles, mRNA cargo delivery and transcription, and cytotoxic responses in real time.

https://bit.ly/4vf0aWn

13/05/2026

𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 𝗽𝗿𝗲𝘀𝗲𝗻𝘁: 𝗖𝗮𝗻𝗰𝗲𝗿 𝗰𝗲𝗹𝗹 𝗱𝗲𝗮𝘁𝗵 𝗮𝗻𝗱 𝗶𝗺𝗺𝘂𝗻𝗲 𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴
Join scientists from MIT, Mass General Hospital and Harvard Medical School as they share their research into immune cell engineering and ferroptosis in cancer cells. In this seminar co-hosted by Nanolive and the Nanowell Cytometry Platform MIT Koch Institute for Integrative Cancer Research, explore real-world applications in cancer cell death and immune engineering, featuring Nanolive’s label-free live cell imaging.

𝙀𝙣𝙜𝙞𝙣𝙚𝙚𝙧𝙞𝙣𝙜 𝙄𝙢𝙢𝙪𝙣𝙚 𝘾𝙚𝙡𝙡𝙨 𝙩𝙤 𝙊𝙫𝙚𝙧𝙘𝙤𝙢𝙚 𝙩𝙝𝙚 𝘾𝙖𝙣𝙘𝙚𝙧 𝘾𝙚𝙡𝙡 𝙂𝙡𝙮𝙘𝙤𝙘𝙖𝙡𝙮𝙭
Sangwoo Park, PhD - Instructor, Mass General Hospital & Harvard Medical School

𝘼 𝙉𝙚𝙬 𝙒𝙞𝙣𝙙𝙤𝙬 𝙞𝙣𝙩𝙤 𝙁𝙚𝙧𝙧𝙤𝙥𝙩𝙤𝙨𝙞𝙨: 𝙇𝙖𝙗𝙚𝙡-𝙁𝙧𝙚𝙚 𝙄𝙢𝙖𝙜𝙞𝙣𝙜 𝙤𝙛 𝘾𝙚𝙡𝙡𝙪𝙡𝙖𝙧 𝘿𝙚𝙖𝙩𝙝
Ryan Mansell - Graduate Student, Koch Institute for Integrative Cancer Research, MIT

First hosted on April 9th, you can now catch up online: https://bit.ly/4dnnMRa

11/05/2026

𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝘁𝗼 𝘀𝗶𝗺𝗽𝗹𝗶𝗳𝘆 𝗶𝗺𝗺𝘂𝗻𝗲 𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁?
Our recent webinar on immune cell therapy screening last week generated some of the highest engagement we have seen this year, with particularly strong discussion around one common challenge: relying on fragmented assays to understand complex immune cell behavior. If you missed the live session, the 𝗿𝗲𝗽𝗹𝗮𝘆 𝗶𝘀 𝗻𝗼𝘄 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗼𝗻 𝗱𝗲𝗺𝗮𝗻𝗱.

In this webinar, we demonstrate how a 𝘀𝗶𝗻𝗴𝗹𝗲, 𝗹𝗮𝗯𝗲𝗹-𝗳𝗿𝗲𝗲 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄 can replace fragmented assays and provide continuous insight into immune cell activation, engagement, and killing dynamics.

- Quantify killing efficacy and rank therapeutic candidates
- Classify T cell activation and exhaustion over time
- Reduce workflow complexity
- Make more confident screening decisions with high-content data

Watch here: https://bit.ly/4nwp01d

06/05/2026

𝗧𝗼𝗱𝗮𝘆'𝘀 𝗲𝘃𝗲𝗻𝘁: 𝗢𝗻𝗲 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄 𝗳𝗼𝗿 𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁
Discover Nanolive’s cell therapy screening workflow, as we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies.

➡️ Register for the Online walkthrough below!
https://bit.ly/4ncMl7R

04/05/2026

𝗟𝗶𝘃𝗲 𝗰𝗲𝗹𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗱𝗮𝘁𝗮 𝘄𝗮𝗹𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵
Join us online on May 6th to discover Nanolive’s cell therapy screening workflow, as we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies. Using real data we will show how to reduce time, costs and errors, by simplifying fragmented assays into a single process to accelerate screening and selection of therapies.

Register now: https://bit.ly/4tYqXpP

From activation to target engagement and killing, Nanolive’s revolutionary technology enables the identification of the most effective therapeutic candidates using live, label-free and automated analysis of effector cell activation, interactions, and killing. This session will present insights from nonadherent AML and CML models with gamma-delta T cells, and human CAR T cells, using the only high-resolution and automated system for quantifying the effector cell response in co-culture.

Stop screening immunotherapies with fragmented assays.

Understand activation, engagement, and killing dynamics in one experiment.

This video shows AI-classification of T cell activation state: T cells with an active morphology are colored cyan, dead T cells are colored brown, and inactive T cells are colored blue.

01/05/2026

𝗗𝗼𝗲𝘀 𝗧 𝗰𝗲𝗹𝗹-𝘁𝗮𝗿𝗴𝗲𝘁 𝗶𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝗼𝗻 𝗴𝘂𝗮𝗿𝗮𝗻𝘁𝗲𝗲 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗸𝗶𝗹𝗹𝗶𝗻𝗴?
Understanding the balance between T cell killing, persistence, and exhaustion is the essential basis for creating effective CAR T cell therapies for cancer and auto-immune conditions. How can heterogeneous T cell responses be studied, and how can CAR T cells be enhanced for improved persistence and efficacy?

Join us online on May 6th to discover Nanolive’s cell therapy screening workflow, as we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies.

Register now: https://bit.ly/3R9pqhN

This video shows four pancreatic cancer cells that are mostly static with smaller T cells crawling and moving very quickly trying to find cancer cells to kill them. Despite the best efforts of the T cells the cancer cells evade them by not being recognized.

27/04/2026

𝗛𝗼𝘄 𝗰𝗮𝗻 𝘄𝗲 𝗮𝘀𝘀𝗲𝘀𝘀 𝗶𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗵𝗮𝗿𝗺𝗳𝘂𝗹 𝗹𝗮𝗯𝗲𝗹𝘀?
Most conventional methods rely on endpoint measurements or destructive sample preparation, which limits the ability to dynamically monitor and quantify effector cell behavior over time.

The LIVE T Cell Assay offers a powerful alternative: continuous, label-free monitoring of effector engagement, killing, and target cell response, all in real time and without stains or dyes. The assay can be seamlessly integrated into your immunotherapy development workflows to support candidate selection, functional validation, and potency testing.
Join us online on May 6th to discover how Nanolive’s non-invasive, AI-powered solution provides dynamic functional readouts and enables scientists to evaluate killing efficiency, optimize CAR-T cell selection, and gain deeper mechanistic insights.

Register now: https://bit.ly/4vNhUcu

In this video, two populations of leukemia cells with T cells are shown side-by-side and cancer cell death is captured in real-time following CAR-T cells' engagement. The leukemia cells have been automatically segmented and classified as living (green) or dead (brown) revealing successful killing by T cells in the left well.

24/04/2026

𝗟𝗮𝗯𝗲𝗹-𝗳𝗿𝗲𝗲 𝗧 𝗰𝗲𝗹𝗹 𝗲𝗳𝗳𝗶𝗰𝗮𝗰𝘆 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁
Early-stage research and development still lack tools that can accurately and dynamically assess immune cell function and potency. Existing technologies such as flow cytometry and fluorescence-based imaging often rely on endpoint measurements and fluorescent labelling, limiting real-time functional insights and introducing bias from phototoxicity. To address these limitations, Nanolive’s label-free technology offers an end-to-end solution for studying therapeutic efficacy and potency of effector cells in real-time.

Join us online on May 6th to discover Nanolive’s cell therapy screening workflow, as we showcase the power of a single assay for assessing efficacy, mechanism, and failure modes of immune cell therapies.

Register now: https://bit.ly/4cmj5rI

Adresse

Route De Lully 5B
Lully
1131

Öffnungszeiten

Montag	09:00 - 17:00
Dienstag	09:00 - 17:00
Mittwoch	09:00 - 17:00
Donnerstag	09:00 - 17:00
Freitag	09:00 - 17:00

Telefon

+41213530600

Webseite

http://nanolive.ch/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Nanolive erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.